Early research (Phase 1)UnknownNCT00599469What this trial is testingFar Infrared Treatment for Alzheimer's DiseaseWho this might be right forAlzheimer Disease GAAD Medical Research Institute Inc. 4
Testing effectiveness (Phase 2)Study completedNCT03518073What this trial is testingLY3303560 in Participants With Early Symptomatic Alzheimer's DiseaseWho this might be right forAlzheimer Disease (AD) Eli Lilly and Company 360
Large-scale testing (Phase 3)Looking for participantsNCT07115238What this trial is testingAnalysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and ADWho this might be right forAlzheimer DiseaseNeurofibrillary Tangle Sinotau Pharmaceutical Group 354
Early research (Phase 1)Study completedNCT02562989What this trial is testing[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)Who this might be right forAlzheimer's DiseaseAmnestic Mild Cognitive Impairment Merck Sharp & Dohme LLC 13
Early research (Phase 1)Active Not RecruitingNCT05361382What this trial is testingHead-to-Head Harmonization of Tau Tracers in Alzheimer's DiseaseWho this might be right forAlzheimer Disease Tharick Pascoal 822
Testing effectiveness (Phase 2)UnknownNCT04169126What this trial is testingTopography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment SubjectsWho this might be right forAlzheimer's Disease Chang Gung Memorial Hospital 300
Early research (Phase 1)Study completedNCT01850238What this trial is testingSafety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's DiseaseWho this might be right forAlzheimer Disease Axon Neuroscience SE 30